older glp 1 drugs GLP-1 weight-loss may lower the need for knee replacement Researchers find GLP-1 medications safe

While further behind alcohol and nicotine research, preliminary studies are examining whether GLP-1 agonists could complement existing treatments like buprenorphine and naltrexone for opioid use disorder

GLP-1 activates the GLP-1R to stimulate adenylate cyclase (AC), increasing intracellular levels of cyclic AMP (cAMP) (Sandoval and DAlessio, 2015)

Data points represent the mean of at least three independent experiments

To bypass the pharmacological challenges associated with unspecific blocking of NMDA receptors, we designed a peptidedrug conjugate comprising the NMDA receptor antagonist MK-801 and a GLP-1 peptide analogue

(2008a)

[DOI] [PubMed] [Google Scholar] 219.Bashshur R.L., Shannon G.W., Smith B.R., Alverson D.C., Antoniotti N., Barsan W.G., Bashshur N., Brown E.M., Coye M.J., Doarn C.R., et al